The Wet Seal, Inc (NASDAQ:WTSL) has been given a consensus recommendation of “Hold” by the eight brokerages that are currently covering the company, American Banking News.com reports. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $2.98. The Wet Seal, Inc. (NASDAQ:WTSL) stock performance was 2.04% in last session and finished the day at $0.950. Traded volume was 1.30million shares in the last session and the average volume of the stock remained 1.71million shares. The beta of the stock remained 0.99. The Wet Seal, Inc. (NASDAQ:WTSL) insider ownership is 3.20%.

eASIC Corporation, a leading provider of Single Mask Adaptable ASIC™ devices and MoSys, Inc. (NASDAQ:MOSY), a leader in semiconductor solutions that enable fast, intelligent data access for network and communications systems, on 13 May 2014 announced successful hardware interoperability at 10.3125Gbps and 12.5Gbps between the MGIO (Multi Gigabit I/O) serial transceivers on eASIC’s Nextreme-3 28nm family and the CEI-11 compatible interface on the MoSys Inc (NASDAQ:MOSY)® Bandwidth Engine® IC. “eASIC is a leader in single mask ASICs and we are pleased to have its support of the GigaChip Interface for its networking customers,” said John Monson, VP of marketing and sales for the company. MoSys Inc. (NASDAQ:MOSY) rose 2.61 percent to $3.14 Thursday on volume of 300,945.00million shares. The intra-day range of the stock was $3.00 to $3.19. MoSys Inc. (NASDAQ:MOSY) has a market capitalization of $155.39million.

MELA Sciences, Inc. (NASDAQ:MELA), developer of the MelaFind system, an optical diagnostic device approved for use in the U.S. and the European Union to assist dermatologists in melanoma diagnosis, on 08 May 2014 announced statistically significant preliminary results of a study that measured the impact of predictive probability information (probability of lesion being melanoma and melanoma/high-grade) on dermatologists’ decisions to biopsy ambiguous pigmented skin lesions. MELA Sciences Inc (NASDAQ:MELA)’s stock on May 22, 2014 reported a increase of 2.72% to the closing price of $0.381. Its fifty two weeks range is $0.36 -$1.20. The total market capitalization recorded $19.86million. The overall volume in the last trading session was 313,456.00million shares. In its share capital, MELA has 52.21million outstanding shares.

Big 5 Sporting Goods Corporation (NASDAQ:BGFV)‘s stock had its “underperform” rating reiterated by analysts at Credit Suisse in a research report issued to clients and investors on Monday, Analyst Ratings News reports. They currently have a $11.00 target price on the stock, down from their previous target price of $14.00. Credit Suisse’s price target would suggest a potential downside of 11.58% from the company’s current price. On Thursday, shares of Big 5 Sporting Goods Corporation (NASDAQ:BGFV) dropped -0.70% to close the day at $11.37. Company return on investment (ROI) is 12.50% and its monthly performance is recorded as -26.36%. Big 5 Sporting Goods Corporation (NASDAQ:BGFV) quarterly revenue growth is -33.31%.